• From Mixer to Mechanism: Better mRNA Data

  2026-08-14

  A thought-leadership guide to using dual fluorescence and bioluminescence reporters to separate mRNA delivery, intracellular trafficking, and translation performance while improving LNP screening and translational decision-making.

• Plastid DNA Breaks in Arabidopsis: A DEtail-seq Map

  2026-08-14

  The reference study uses DNA end tailing and sequencing (DEtail-seq) to provide a genome-wide map of plastid DNA breaks across Arabidopsis development and environmental conditions. Its findings connect plastid genome instability with tissue age, DNA repair defects, R-loops, reactive oxygen species, and probable 8-oxoG-mediated damage, creating a framework for studying organellar genome maintenance.

• Caspase-3 Colorimetric Assay Kit in ER Stress

  2026-08-13

  The Caspase-3 Colorimetric Assay Kit provides a practical way to test whether ER stress and inflammatory remodeling in intestinal macrophages involve executioner-caspase activity. This article connects the K2008 assay to the IgSF6 study while emphasizing controls, interpretation, and orthogonal validation.

• Epoxomicin for Proteasome Pathway Assays

  2026-08-13

  Epoxomicin is a selective, irreversible proteasome inhibitor for resolving how proteasomal turnover shapes ER stress, protein quality control, inflammation, and neurodegeneration models. This practical guide connects its covalent mechanism and 4 nM chymotrypsin-like activity to assay design, dosing, controls, and troubleshooting.

• Pravastatin sodium: A Mechanism-to-Assay Guide

  2026-08-12

  Pravastatin sodium is a selective HMG-CoA reductase inhibitor with applications in cholesterol biosynthesis inhibition and LDL cholesterol reduction. This guide translates transporter and hepatocyte findings into a practical framework for separating target engagement, cytotoxicity, and disposition effects in research assays.

• Berberrubine Chloride: From Mechanism to Translation

  2026-08-12

  Berberrubine chloride offers translational researchers a mechanism-rich platform spanning nucleotide metabolism, redox control, inflammatory signaling, urate transport, and tumor biology. This thought-leadership perspective connects biochemical evidence, structure–activity insight, assay design, and preclinical strategy while clarifying the limitations that must be addressed before clinical interpretation.

• NF 449 for P2X1 Platelet Research

  2026-08-11

  NF 449 is a high-potency purinergic receptor antagonist for separating P2X1-driven platelet signaling from P2Y1 and P2Y12 activity. This guide translates the reference findings into practical aggregation, calcium-flux, collagen-response, and thrombosis workflows, with troubleshooting advice for concentration, selectivity, and assay variability.

• SU5416 Workflow for VEGFR2 Angiogenesis Studies

  2026-08-11

  SU5416 (Semaxanib) gives researchers a practical way to separate VEGF–VEGFR2 signaling from broader vascular-cell metabolic effects. This workflow combines target-engagement assays, angiogenesis phenotyping, normoxic HIF1α controls, and troubleshooting for more reproducible cancer and vascular research.

• Bacitracin (B1670): Research Workflow Guide

  2026-08-10

  Bacitracin (B1670) is a peptide antibiotic for controlled antibacterial research involving bacterial cell wall and peptidoglycan synthesis disruption. It is intended for scientific research use only and should not be used for diagnostic, therapeutic, or other medical applications.

• Deferasirox Workflows for Iron and Lysosomal Stress

  2026-08-09

  Deferasirox provides a practical way to perturb iron availability while researchers dissect glucose-starvation responses, ferritinophagy, and lysosome-dependent cell death. This workflow separates direct chelation effects from TCF25–V-ATPase biology and adds orthogonal assays for stronger mechanistic conclusions.

• Vidarabine Monohydrate: Assay Workflow Guide

  2026-08-08

  This scenario-based guide explains how Vidarabine monohydrate, SKU C6377, can support controlled antiviral, viability, proliferation, and cytotoxicity workflows. It focuses on solvent compatibility, assay interpretation, dose design, and practical vendor-selection criteria without overstating biological efficacy.

• Capsaicin Research Workflows for TRPV1 and KDM1A

  2026-08-07

  Capsaicin supports a distinctive two-track research strategy: TRPV1 ion channel activation for pain and inflammation studies, alongside KDM1A/LSD1 inhibition for gastric cancer and epigenetic assays. This practical guide connects compound handling, dose selection, orthogonal validation, and troubleshooting for more reproducible cell and translational models.

• CX-5461 Induces DNA Damage and Mitotic Catastrophe in Cervic

  2026-08-07

  The reference study demonstrates that the RNA polymerase I inhibitor CX-5461 suppresses cervical cancer cell proliferation by inducing DNA damage and mitotic catastrophe, while also enhancing cisplatin sensitivity. These mechanistic insights highlight the therapeutic potential of targeting ribosome biogenesis in treatment-resistant cervical cancer.

• Cy5 Goat Anti-Mouse IgG (H+L) Antibody: Precision in Hybrid

  2026-08-06

  Explore how the Cy5 Goat Anti-Mouse IgG (H+L) Antibody enhances sensitivity and multiplexing in advanced immunoassays, with a special focus on its role in evaluating ferritin-based hybrid vaccines. This in-depth analysis delivers unique insights for researchers seeking robust, scalable detection strategies.

• Cy3 NHS Ester (Non-Sulfonated): Technical Guide and Protocol

  2026-08-06

  Cy3 NHS ester (non-sulfonated) enables sensitive, amine-reactive fluorescent labeling of proteins, peptides, and oligonucleotides for imaging and detection applications. It is best suited for workflows that tolerate organic co-solvents such as DMSO or DMF, and is not recommended for strictly aqueous labeling or highly labile proteins. This article provides protocol parameters, troubleshooting, and workflow guidance relevant to biomedical research.

8603 records 5/574 page Previous Next 12345 下5页 Last page